Hutchmed China Ltd is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines to address unmet medical needs, particularly in oncology and immunology. The company leverages its strong research capabilities and expertise in understanding Chinese and global markets to develop targeted therapies. Hutchmed is committed to bringing novel treatments to patients, with an emphasis on leveraging cutting-edge science and technology to advance cancer treatments and improve patient outcomes. Through its robust pipeline and strategic partnerships, the company aims to expand its impact in the rapidly evolving healthcare landscape.